How Trump's New Generic Drug Tariff Plan Could Hit India The latest development in the ongoing trade tensions between the United States and India has significant implications for the latter, often referred to as the "pharmacy of the world.
" President Donald Trump's announcement of a phased tariff plan for imported generic medicines has sparked concern among Indian drugmakers.
The proposed tariff regime is part of Trump's broader strategy to bring pharmaceutical manufacturing back to the United States.